@article{48634a9813b74c9a916033a4d60b4b64,
title = "Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity",
keywords = "Arrhythmias, Cardio-oncology, Cardiotoxicity, Hypertension 5{\textquoteright} AMP-activated protein kinase (AMPK), Intracellular signaling, Phosphoinositide 3-kinase (PI3K) signaling, Tyrosine kinase inhibitors (TKIs), Vascular endothelial growth factor receptor (VEGFR)",
author = "Scott, {Shane S.} and Greenlee, {Ashley N.} and Anna Matzko and Matthew Stein and Naughton, {Michael T.} and Zaramo, {Taborah Z.} and Schwendeman, {Ethan J.} and Mohammad, {Somayya J.} and Mamadou Diallo and Rohith Revan and Gabriel Shimmin and Shwetabh Tarun and Joel Ferrall and Ho, {Thai H.} and Smith, {Sakima A.}",
note = "Funding Information: The authors report that this work was supported by the following grants T32HL134616 and R01 NIHMS1018036. ",
year = "2022",
month = jul,
doi = "10.1016/j.hfc.2022.02.003",
language = "English (US)",
volume = "18",
pages = "425--442",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "3",
}